MEDICAL NEWS TODAY | DAILY NEWS
Recently, the FDA has approved an oral PCSK9 inhibitor, Lipfendra, for the treatment of high cholesterol. A cardiologist explains how it compares to statins, who this treatment is for, and why.
 
MEDICALNEWSTODAY | DAILY NEWS
 
Today’s News
Updated on August 4, 2026 at 8:00 a.m. PST
 
How does Lipfendra compare to statins? Expert answers 5 key questions
 
How does Lipfendra compare to statins? Expert answers 5 key questions
READ ON
→
4 Best CBD Creams for Arthritis Pain in 2026
 
4 Best CBD Creams for Arthritis Pain in 2026
READ ON
→
What to know about the size of ovarian tumors
 
What to know about the size of ovarian tumors
READ ON
→
 
Read Latest news
 
 
MNT REVIEWS
LetsGetChecked Review: Are Home Health Tests Worth It?
 
Complete LetsGetChecked review. Test for vitamins, thyroid, and more at home. We examine accuracy, doctor oversight, and when to skip the kit and see your physician.
SHOP NOW
 
What to know about hypoparathyroidism
MNT RESOURCE
What to know about hypoparathyroidism
Hypoparathyroidism occurs when the parathyroid glands, located in the neck, do not produce enough parathyroid hormone. Learn more here.
READ ON  
 
 
NEW PODCAST EPISODE
ADHD: Why do women get missed out?
 
ADHD: Why do women get missed out?
Hosted by Maria Cohut and Yasemin Nikola Sakay
Why does it take longer for women to receive an ADHD diagnosis, and should our understanding of ADHD change? Prof. Davida Hartman, autism and ADHD specialist, joins In Conversation to answer these and other questions.
LISTEN TO THIS EPISODE
LISTEN ON Spotify   Listen on Apple Podcasts  
 
 
Most popular with MNT readers
• What you should